|
FTSJD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.982500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.62649999971387E-07 |
| Normal-vs-Stage2 |
7.059000E-01 |
| Normal-vs-Stage3 |
9.249800E-01 |
| Normal-vs-Stage4 |
3.044400E-02 |
| Stage1-vs-Stage2 |
8.299600E-02 |
| Stage1-vs-Stage3 |
1.474970E-01 |
| Stage1-vs-Stage4 |
7.068000E-01 |
| Stage2-vs-Stage3 |
7.265200E-01 |
| Stage2-vs-Stage4 |
9.449600E-02 |
| Stage3-vs-Stage4 |
1.644430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.202280E-03 |
| Normal-vs-AfricanAmerican |
1.001120E-03 |
| Normal-vs-Asian |
1.318350E-01 |
| Caucasian-vs-AfricanAmerican |
7.458200E-01 |
| Caucasian-vs-Asian |
9.192000E-01 |
| AfricanAmerican-vs-Asian |
7.758800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.623740E-04 |
| Normal-vs-Female |
5.280200E-02 |
| Male-vs-Female |
2.530800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.76449999999396E-05 |
| Normal-vs-Extreme_Weight |
2.004000E-03 |
| Normal-vs-Obese |
3.905200E-01 |
| Normal-vs-Extreme_Obese |
1.246850E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.733000E-01 |
| Normal_Weight-vs-Obese |
4.317600E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.275600E-01 |
| Extreme_Weight-vs-Obese |
1.175550E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.440000E-01 |
| Obese-vs-Extreme_Obese |
2.033700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.053000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.301040E-03 |
| Normal-vs-Age(61-80Yrs) |
9.007700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.49190000004107E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.046550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.015800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.523300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.799400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.638320E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.891900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26889999999091E-05 |
| Normal-VS-Type2 PRCC |
1.388570E-01 |
| Normal-VS-KIRP CIMP |
9.253200E-01 |
| Normal-VS-Unclassified PRCC |
7.186300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.404800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.225600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.393200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.060400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.205600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.777800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.626200E-02 |
| Normal-vs-N1 |
9.052200E-01 |
| Normal-vs-N2 |
3.259700E-03 |
| N0-vs-N1 |
3.027200E-01 |
| N0-vs-N2 |
5.457800E-01 |
| N1-vs-N2 |
2.545200E-01 |
|
|
